T-Lymphocyte Kv1.3 Channel Activation Triggers the NLRP3 Inflammasome Signaling Pathway in Hypertensive Patients

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2017.4490
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Porphyromonas Gingivalis Triggers NLRP3-mediated Inflammasome Activation in Macrophages in a Bacterial Gingipains-Independent Manner

European Journal of Immunology
AllergyImmunology
2018English

Active MLKL Triggers the NLRP3 Inflammasome in a Cell-Intrinsic Manner

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

NLRP3 Inflammasome Activation by Paracoccidioides Brasiliensis

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2013English

Acute Exercise-Induced Mitochondrial Stress Triggers an Inflammatory Response in the Myocardium via NLRP3 Inflammasome Activation With Mitophagy

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2016English

Physiological Role of Kv1.3 Channel in T Lymphocyte Cell Investigated Quantitatively by Kinetic Modeling

PLoS ONE
Multidisciplinary
2014English

Inhibition of Nrf2/Ho-1 Signaling Leads to Increased Activation of the NLRP3 Inflammasome in Osteoarthritis

Arthritis Research & Therapy
2019English

Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages

Immunity
Infectious DiseasesAllergyImmunology
2018English

Oncogenic KrasG12D Causes Myeloproliferation via NLRP3 Inflammasome Activation

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Glibenclamide Alleviates Inflammation in Oleic Acid Model of Acute Lung Injury Through NLRP3 Inflammasome Signaling Pathway

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy